Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Gastroenterology
•
Gastrointestinal Functional & Motility Disorders
•
Primary Care
Are there data to support the use of herbal supplements, prebiotics, or probiotics in the management of SIBO?
Related Questions
How do people approach non-HIV patients with hepatitis B, a negative Hepatitis B E antigen, normal LFTs and relatively low HBV DNA between 2000-20000?
What adjunctive therapies beyond an antisecretory agent (e.g., PPI, H2RA, etc.) do you find most helpful in managing the acute symptoms of PUD?
What is your advice to patients with IBD who are on biologic therapies and planning for pregnancy?
Do you recommend the use of SGLT2 inhibitors to reduce the risk of liver cirrhosis in patients with Type 2 diabetes mellitus?
Do you avoid the use of GLP-1 R agonist therapy for treatment of obesity in patients with known gastroparesis?
How do you adjust medications for patients with eosinophilic esophagitis who responded to budesonide or PPI, and when do you repeat EGD?
Can patients "age out" of screening colonoscopies if on their last colonoscopy prior to turning 76, they had tubular adenomas?
When and how should we be stopping GLP-1 Receptor Agonist/Dual Agonist therapy?
How do you approach a referral for findings of intestinal metaplasia on a biopsy of an irregular z-line?
In a patient with well-controlled ulcerative colitis on tofacitinib for several years, would you consider switching to upadacitinib for a more favorable side effect profile?
